Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing
Keyword(s):
2018 ◽
Vol 102
(4)
◽
pp. 683-696
◽
2005 ◽
Vol 24
(3)
◽
pp. 153-161
◽
Keyword(s):
Keyword(s):